Cargando…
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients
Vulvar cancer incidence numbers have been rising steadily over the past decades. Especially the number of young patients with vulvar cancer increased recently. Therefore, the need to identify new prognostic factors for vulvar carcinoma is more apparent. Cyclooxygenase-2 (COX-2) has long been an obje...
Autores principales: | Ansorge, Nadine, Dannecker, Christian, Jeschke, Udo, Schmoeckel, Elisa, Mayr, Doris, Heidegger, Helene H., Vattai, Aurelia, Burgmann, Maximiliane, Czogalla, Bastian, Mahner, Sven, Fuerst, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001561/ https://www.ncbi.nlm.nih.gov/pubmed/33802010 http://dx.doi.org/10.3390/diagnostics11030491 |
Ejemplares similares
-
Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2022) -
LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients
por: Wanka, Giulia, et al.
Publicado: (2020) -
EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer
por: Buchholz, Anna, et al.
Publicado: (2021) -
Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022) -
MTA1 as negative prognostic marker in vulvar carcinoma
por: Wanka, Giulia, et al.
Publicado: (2023)